Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women

Circulation Journal

Volumn 71, Issue 10, 2007, Pages 1555-1559

  Sumino, Hiroyuki ^a   Ichikawa, Shuichi ^b   Kasama, Shu ^b   Takahashi, Takashi ^c   Sakamoto, Hironosuke ^a   Kumakura, Hisao ^b   Takayama, Yoshiaki ^b   Kanda, Tsugiyasu ^c   Murakami, Masami ^d   Kurabayashi, Masahiko ^d  

^a TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b Cardiovascular Hospital of Central Japan   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone mass; Endothelial function; Menopause; Women

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; BRACHIAL ARTERY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOTHELIAL DYSFUNCTION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; VASODILATATION;

ABSORPTIOMETRY, PHOTON; AGED; ATHEROSCLEROSIS; BONE DENSITY; BONE DISEASES, METABOLIC; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; REGRESSION ANALYSIS; RISK FACTORS; VASODILATION;

EID: 34948841571     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1555     Document Type: Article

References (33)

1. von der Recke P, Hansen MA, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999; 106: 273-278.
2. Mosca L, Manson JE, Sutherland SE, Langer RD, Barrett-Connor E. Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association Writing Group. Circulation 1997; 96: 2468-2482.
3. Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 1998; 62: 209-213.
4. Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC. Progression of aortic calcification is associated with metacarpal bone loss during menopause: A population-based longitudinal study. Arterioscler Thromb Vasc Biol 2000; 20: 1926-1931.
5. Sanada M, Taguchi A, Higashi Y, Tsuda M, Kodama I, Yoshizumi M, et al. Forearm endothelial function and bone mineral loss in postmenopausal women. Atherosclerosis 2004; 176: 387-392.
6. Hirose K, Tomiyama H, Okazaki R, Arai T, Koji Y, Zaydun G, et al. Increased pulse wave velocity associated with reduced calcaneal quantitative osteo-sono index: Possible relationship between atherosclerosis and osteopenia. J Clin Endocrinol Metab 2003; 88: 2573-2578.
7. Uyama O, Yoshimoto Y, Yamamoto Y, Kawai A. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 1997; 28: 1730-1732.
8. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
9. Anggard E. Nitric oxide: Mediator, murderer, and medicine. Lancet 1994; 343: 1199-1206.
10. Kanis JA, Melton III LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-1141.
11. Gotoh M, Mizuno K, Ono Y, Takahashi M. High blood pressure, bone-mineral loss and insulin resistance in women. Hypertens Res 2005; 28: 565-570.
12. Sumino H, Ichikawa S, Ohyama Y, Takahashi T, Saito Y, Nakamura T, et al. Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women. Am J Cardiol 2005; 96: 148-153.
13. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure: Possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005; 69: 221-226.
14. Tanriverdi H, Evrengul H, Tanriverdi S, Turgut S, Akdag B, Kaftan HA, et al. Improved endothelium dependent vasodilation in endurance athletes and its relation with ACE I/D polymorphism. Circ J 2005; 69: 1105-1110.
15. Sumino H, Ichikawa S, Kasama S, Takahashi T, Kumakura H, Takayama Y, et al. Elevated arterial stiffness in postmenopausal women with osteoporosis. Maturitas 2006; 55: 212-218.
16. Cohn JN. Vascular wall function as a risk marker for cardiovascular disease. J Hypertens 1999; 17(Suppl 5): S41-S44.
17. Kalin MF, Zumoff B. Sex hormones and coronary disease: A review of the clinical studies. Steroids 1990; 55: 330-352.
18. Bauer DC, Browner WS, Cauley JA, Orwoll ES, Scott JC, Black DM, et al. Factors associated with appendicular bone mass in older women: The Study of Osteoporotic Fractures Research Group. Ann Intern Med 1993; 118: 657-665.
19. Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988; 241: 84-86.
20. Oursler M, Peterson L, Fitzpatrick I, Riggs BL, Spelsberg TC. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA 1994; 91: 5227-5231.
21. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-1811.
22. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993; 329: 1141-1146.
23. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
24. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314-1319.
25. Kelly PJ, Montgomery RJ, Bronk JT. Reaction of the circulatory system to injury and regeneration. Clin Orthop Relat Res 1990; 254: 275-288.
26. Hauschka PV, Lian JB, Cole DEC, Gundeberg CM. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 1989; 69: 990-1047.
27. Braam LA, Dissel P, Gijsbers BL, Spronk HM, Hamulyak K, Soute BA, et al. Assay for human matrix Gla protein in serum: Potential applications in the cardiovascular field. Arterioscler Thromb Vasc Biol 2000; 20: 1257-1261.
28. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001; 21: 1998-2003.
29. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: Incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993; 95: 197-202.
30. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-1792.
31. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997; 17: 680-687.
32. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993; 92: 1686-1696.
33. Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K, et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002; 106: 1192-1194.